Overview

Dose-Escalating Multiple Dose Study of PD-0360324 in Combination With Methotrexate in Patients With Rheumatoid Arthritis

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the safety and tolerability of multiple intravenously administered doses of PD 0360324 in patients with rheumatoid arthritis receiving methotrexate.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Methotrexate